Zymeworks (ZYME) Misses Q3 EPS by 39c
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Join SI Premium – FREE
Zymeworks (NASDAQ: ZYME) reported Q3 EPS of ($0.39). Revenue for the quarter came in at $16 million.
For earnings history and earnings-related data on Zymeworks (ZYME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Starts Boyd Gaming (BYD) at Buy
- ITG targets $2.67 billion valuation in U.S. IPO
- Clearmind completes Part A of FDA-regulated AUD drug trial
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
